Summary
https://kalkinemedia.com/au/sponsor...ettle-with-a-slew-of-developments-across-q321
- SUDA Pharmaceuticals Ltd (ASX:SUD) released its Appendix 4C for the consolidated group for the third quarter of FY 2021 (Q321).
- The firm continued to make major strides across Q321 and SUDA’s cash balance was A$4.28 million by the end of the period.
- The team has uncovered new technologies that are currently under review.
Ann: Quarterly Appendix 4C and Activities Report, page-26
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $173.5M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 16.0¢ | $42.03K | 259.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 223777 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 965274 | 13 |
View Market Depth
| Last trade - 11.29am 01/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |